BNTX BioNTech SE
BNTX BioNTech SE
Healthcare · Biotechnology
Desk view
Market read
Scan convergence 1 scan as of 2026-10-16 1 bear converging
POC $91.57 · VWAP $97.55 · -9.7% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Coverage
3 watchlists
BNTX Price Structure
Loading timeframes…
Peers
Every watchlist BNTX belongs to, members best 30-day change first — BNTX highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@ibb
@biotech-scan
@insider-universe
Against street estimates
How BNTX's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. A consensus out of line with the name's earlier estimates (opposite sign to all of them and over 3x their size) is not graded. EPS only.
News (last pull)
Headlines about BNTX from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 31 days ago · Sep 22
- BioNTech launches USD 1.0B ADS share buyback | BNTX SEC Filing - Form 6-K
- BioNTech Announces Second Quarter 2026 Financial Results and ...
- BioNTech (BNTX) Investor Relations, Earnings Summary & Outlook
- BNTX Q2 2026 Earnings Report on 8/4/2026 - MarketBeat
- BioNTech (BNTX) Earnings Date & Report - Investing.com
BNTX research tape
88 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.